583 related articles for article (PubMed ID: 9058829)
1. In vitro prevention and reversal of lipopolysaccharide desensitization by IFN-gamma, IL-12, and granulocyte-macrophage colony-stimulating factor.
Randow F; Döcke WD; Bundschuh DS; Hartung T; Wendel A; Volk HD
J Immunol; 1997 Mar; 158(6):2911-8. PubMed ID: 9058829
[TBL] [Abstract][Full Text] [Related]
2. Granulocyte-macrophage colony-stimulating factor and IFN-gamma restore the systemic TNF-alpha response to endotoxin in lipopolysaccharide-desensitized mice.
Bundschuh DS; Barsig J; Hartung T; Randow F; Döcke WD; Volk HD; Wendel A
J Immunol; 1997 Mar; 158(6):2862-71. PubMed ID: 9058823
[TBL] [Abstract][Full Text] [Related]
3. ONO-4007, an antitumor lipid A analog, induces tumor necrosis factor-alpha production by human monocytes only under primed state: different effects of ONO-4007 and lipopolysaccharide on cytokine production.
Matsumoto N; Aze Y; Akimoto A; Fujita T
J Pharmacol Exp Ther; 1998 Jan; 284(1):189-95. PubMed ID: 9435177
[TBL] [Abstract][Full Text] [Related]
4. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor on tumor necrosis factor and interleukin-1 production in human monocytes.
Essner R; Rhoades K; McBride WH; Morton DL; Economou JS
J Clin Lab Immunol; 1990 Aug; 32(4):161-6. PubMed ID: 1966932
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-4 suppresses granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in stimulated human monocytes.
Hamilton JA; Whitty GA; Royston AK; Cebon J; Layton JE
Immunology; 1992 Aug; 76(4):566-71. PubMed ID: 1383133
[TBL] [Abstract][Full Text] [Related]
7. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
Ferret-Bernard S; Saï P; Bach JM
Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
[TBL] [Abstract][Full Text] [Related]
8. Regulation of hepatic endothelial cell and macrophage proliferation and nitric oxide production by GM-CSF, M-CSF, and IL-1 beta following acute endotoxemia.
Feder LS; Laskin DL
J Leukoc Biol; 1994 Apr; 55(4):507-13. PubMed ID: 8145021
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-13 effects on activated monocytes lead to novel cytokine secretion profiles intermediate between those induced by interleukin-10 and by interferon-gamma.
Minty A; Ferrara P; Caput D
Eur Cytokine Netw; 1997 Jun; 8(2):189-201. PubMed ID: 9262968
[TBL] [Abstract][Full Text] [Related]
10. Regulation of tumor necrosis factor-alpha production and gene expression in monocytes.
Kohn FR; Phillips GL; Klingemann HG
Bone Marrow Transplant; 1992 May; 9(5):369-76. PubMed ID: 1617321
[TBL] [Abstract][Full Text] [Related]
11. Culture of human monocytes with granulocyte-macrophage colony-stimulating factor results in enhancement of IFN-gamma receptors but suppression of IFN-gamma-induced expression of the gene IP-10.
Finbloom DS; Larner AC; Nakagawa Y; Hoover DL
J Immunol; 1993 Mar; 150(6):2383-90. PubMed ID: 8450219
[TBL] [Abstract][Full Text] [Related]
12. Synergistic activation of human monocytes by granulocyte-macrophage colony-stimulating factor and IFN-gamma. Increased TNF-alpha but not IL-1 activity.
Hart PH; Whitty GA; Piccoli DS; Hamilton JA
J Immunol; 1988 Sep; 141(5):1516-21. PubMed ID: 3137258
[TBL] [Abstract][Full Text] [Related]
13. Role of the cytokine environment and cytokine receptor expression on the generation of functionally distinct dendritic cells from human monocytes.
Conti L; Cardone M; Varano B; Puddu P; Belardelli F; Gessani S
Eur J Immunol; 2008 Mar; 38(3):750-62. PubMed ID: 18236400
[TBL] [Abstract][Full Text] [Related]
14. Increased tolerance to endotoxin by granulocyte-macrophage colony-stimulating factor-deficient mice.
Basu S; Dunn AR; Marino MW; Savoia H; Hodgson G; Lieschke GJ; Cebon J
J Immunol; 1997 Aug; 159(3):1412-7. PubMed ID: 9233638
[TBL] [Abstract][Full Text] [Related]
15. IFN-gamma and LPS overcome glucocorticoid inhibition of priming for superoxide release in human monocytes. Evidence that secretion of IL-1 and tumor necrosis factor-alpha is not essential for monocyte priming.
Szefler SJ; Norton CE; Ball B; Gross JM; Aida Y; Pabst MJ
J Immunol; 1989 Jun; 142(11):3985-92. PubMed ID: 2541203
[TBL] [Abstract][Full Text] [Related]
16. The role of granulocyte-macrophage colony-stimulating factor in induction of monocytic differentiation of HL-60 cells: synergistic interaction with 1 alpha, 25-dihydroxyvitamin D3 and interferon-gamma in inducing interleukin-1 beta.
Nakamaki T; Kawakami K; Sato S; Hino K; Tomoyasu S; Tsuruoka N; Honma Y; Hozumi M
Anticancer Res; 1992; 12(5):1331-7. PubMed ID: 1444189
[TBL] [Abstract][Full Text] [Related]
17. Induction of surface tumor necrosis factor (TNF) expression and possible facilitation of surface TNF release from human monocytic cells by granulocyte-macrophage colony-stimulating factor or gamma interferon in combination with 1,25-dihydroxyvitamin D3.
Kelsey SM; Allen PD; Razak K; Macey MG; Newland AC
Exp Hematol; 1993 Jul; 21(7):864-9. PubMed ID: 8319779
[TBL] [Abstract][Full Text] [Related]
18. Regulatory effects of T cell lymphokines on cytokine gene expression in monocytes.
Cluitmans FH; Esendam BH; Landegent JE; Willemze R; Falkenburg JH
Lymphokine Cytokine Res; 1993 Dec; 12(6):457-64. PubMed ID: 8123762
[TBL] [Abstract][Full Text] [Related]
19. Prevention and reversal of tumor cell-induced monocyte deactivation by cytokines, purified protein derivative (PPD), and anti-IL-10 antibody.
Baj-Krzyworzeka M; Baran J; Szatanek R; Stankiewicz D; Siedlar M; Zembala M
Cancer Immun; 2004 Aug; 4():8. PubMed ID: 15327279
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cytokine activation processes in vitro by tenidap, a novel anti-inflammatory agent.
McNiff PA; Laliberte RE; Svensson L; Pazoles CJ; Gabel CA
Cytokine; 1995 Feb; 7(2):196-208. PubMed ID: 7780040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
